about
Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients.The Effectiveness of Pemetrexed Monotherapy Depending on Polymorphisms in TS and MTHFR Genes as Well as Clinical Factors in Advanced NSCLC Patients.Septin 9 promoter region methylation in free circulating DNA-potential role in noninvasive diagnosis of lung cancer: preliminary report.Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes.EGFR gene mutations in patients with adenosquamous lung carcinoma.Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients.Screening for ALK abnormalities in central nervous system metastases of non-small-cell lung cancer.The polymorphism of the CHRNA5 gene and the strength of nicotine addiction in lung cancer and COPD patients.The applicability of a predictive index for second- and third-line treatment of unselected non-small-cell lung cancer patients.The qualification of docetaxel or erlotinib for second-line therapy should be based on clinical and molecular predictive factorsCorrelation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patientsDendritic cells stimulated by MUC1 antigen could induce lymphocytes' anergy through PD-L2 but not through PD-L1 patwayAcute hypersensitivity pneumonitis in woodworkers caused by inhalation of birch dust contaminated with <i>Pantoea agglomerans</i> and <i>Microbacterium barkeri</i>
P50
Q34491507-B62F1011-0F77-43B6-8798-0DAA8F02285BQ36378565-33EAD470-0B2C-480D-A653-C330AB9FE69FQ37677042-A088DB4E-394C-46BB-AAB3-758BA8B0E124Q42061324-AEDA51EA-36AC-488E-A441-9F5256E16C17Q44690866-5EBD9952-EEC0-47D6-A8DF-E5B8E02621ABQ47686349-39CC4DBB-82E2-4ACC-BBB5-4E52AFA2EB40Q48419474-5672B159-CCCC-4A54-8115-405AA91FDF5FQ52299483-05249FAC-E678-476D-8ED1-77562E3EBB5FQ54619423-4DB36F04-FA30-4CD2-AF2A-685BD5D8D561Q83457600-F1DBE60F-7E16-4A54-9316-697241F51D48Q85359341-47C1B5D2-3C5D-4811-BA73-EC7230412C89Q87260255-4E6B3965-E87F-47E3-9122-EC9FF88C7634Q92305986-27D46ABE-60C2-48BD-B5C6-4A7C2981290E
P50
description
investigador
@es
researcher
@en
name
Tomasz Kucharczyk
@en
type
label
Tomasz Kucharczyk
@en
prefLabel
Tomasz Kucharczyk
@en
P31
P496
0000-0002-2678-8655